A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

Aaron Ashby was pulled in the second inning of Monday's spring training showdown between the Milwaukee Brewers and Cincinnati Reds due to an oblique injury.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...

When we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...

Ischemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

“The perception is that the only people who have strokes are older people. You know, 60, 70, 80, 90. However, about 18 percent of strokes happen in young people, and this percentage is rising,” Dr.

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

Divorce can be painful for children of separating parents, but new research out of the University of Texas at Arlington ...